-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Scopolamine Hydrobromide in Motion Sickness
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Scopolamine Hydrobromide in Motion Sickness Drug Details: Scopolamine hydrobromide is under development for the prevention...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RG-6433 in Metastatic Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. RG-6433 in Metastatic Colorectal Cancer Drug Details: RG-6433 (RLY-1971) is under development for the treatment...
-
Track & Monitor
Artificial intelligence in automotive: Motion based segmentation
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Motion based segmentation segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tradipitant in Functional (Non Ulcer) Dyspepsia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tradipitant in Functional (Non Ulcer) Dyspepsia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tradipitant in Functional (Non Ulcer) Dyspepsia Drug Details: Tradipitant (VLY-686,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tradipitant in Gastroparesis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tradipitant in Gastroparesis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tradipitant in Gastroparesis Drug Details: Tradipitant (VLY-686, LY-686017) is under development for the...
-
Thematic Analysis
Quantum Computing – Thematic Intelligence
Quantum Computing Theme Analysis Report Overview Quantum computers use the properties of quantum physics to store data and perform computations. There are many technologies with the potential to build their foundational quantum bits (qubits). However, it may well be over a decade before companies can deliver the enmeshed systems of high-fidelity qubits needed to usher in the quantum era. The fiendishly difficult engineering problems, excess hype, and pre-revenue phase for many quantum companies mean a protracted quantum winter is in...
-
Track & Monitor
Virtual and augmented reality in automotive: Motion compensated AR/VR
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Motion compensated AR/VR segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Sector Analysis
Spinal Non-Fusion Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Spinal Non-Fusion Market Report Overview The spinal non-fusion market size was $884.8 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Spinal non-fusion surgery is performed to treat spinal instability, degenerative disc disorder, and spinal stenosis while preserving the spine's normal motion, load bearing, and shock absorption capacity. Spinal non-fusion surgery also provides pain relief without major anatomical removal. Spinal Non-Fusion Market Outlook, 2023-2033 ($ Million) Buy the Full Report for...
-
Product Insights
NewCharcot-Marie-Tooth Disease Type II – Drugs In Development, 2024
Empower your strategies with our Charcot-Marie-Tooth Disease Type II – Drugs In Development, 2024 report and make more profitable business decisions. Charcot–Marie–Tooth disease (CMT) is a hereditary motor and sensory neuropathy of the peripheral nervous system characterized by progressive loss of muscle tissue and touch sensation across various parts of the body. Symptoms include Loss of touch sensation in the feet, ankles, and legs as well as in the hands, wrists, and arms occurs with various types of the disease. CMT...
-
Product Insights
NewCharcot-Marie-Tooth Disease – Drugs In Development, 2024
Empower your strategies with our Charcot-Marie-Tooth Disease – Drugs In Development, 2024 report and make more profitable business decisions. Charcot-Marie-Tooth disease (CMT) is a term for a group of inherited genetic disorders that affect the peripheral nerves, which connect the brain and spinal cord to the muscles and sensory organs. CMT causes progressive weakness, muscle wasting, and loss of sensation in the feet, legs, hands, and arms. It can also cause foot deformities such as high arches or flat feet. CMT...